Read more biotechnology stories on Newserhttp://www.newser.com/taggrid/3219/biotechnology.html2009 - Newseren-usNewser Feed GeneratorTue, 24 Nov 2009 5:10:36 CSThttp://www.newser.com/story/72544/rich-may-evolve-into-own-species.html?utm_source=syn&utm_medium=rss&utm_campaign=tagThe super wealthy will have such access to high levels of health care, biotechnology and robotics that they could develop into their own species of being, argues a Silicon Valley futurist. The rich will be able to grow their own organs and manipulate genetics for superior abilities and freedom from...http://www.newser.com/story/72544/rich-may-evolve-into-own-species.html?utm_source=syn&utm_medium=rss&utm_campaign=tagMon, 26 Oct 2009 4:41:59 CDThttp://www.newser.com/story/72331/drug-makers-big-spending-pays-off-on-hill.html?utm_source=syn&utm_medium=rss&utm_campaign=tagDrugmakers could get quite a gift from the health care reform bill. Senate and House amendments passed this summer give the makers of biologics—next-generation wonder drugs derived from living matter—12 years of exclusivity on their hyperexpensive products. That’s 7 more years than normal drugs get, and critics say...http://www.newser.com/story/72331/drug-makers-big-spending-pays-off-on-hill.html?utm_source=syn&utm_medium=rss&utm_campaign=tagThu, 22 Oct 2009 12:33:35 CDThttp://www.newser.com/story/53160/roche-gets-genentech-in-468b-biotech-deal.html?utm_source=syn&utm_medium=rss&utm_campaign=tagSwiss drug giant Roche has succeeded in its quest to own biotech firm Genentech outright, and will purchase the 44% of shares it does not already own for $95 each, the San Francisco Chronicle reports today. The $46.8 billion deal comes after months of haggling, wherein Roche offered as...http://www.newser.com/story/53160/roche-gets-genentech-in-468b-biotech-deal.html?utm_source=syn&utm_medium=rss&utm_campaign=tagThu, 12 Mar 2009 6:00:00 CDThttp://www.newser.com/story/50490/new-robotic-arm-takes-cues-from-brain.html?utm_source=syn&utm_medium=rss&utm_campaign=tagArtificial limbs have come a long way from the wooden legs and plastic arms of old: Today's prosthetics take messages directly from the brain. Their performance far exceeds that of the previous generation of devices, which required concentrated effort to make ungainly motions. "You think, and then your muscles move,...http://www.newser.com/story/50490/new-robotic-arm-takes-cues-from-brain.html?utm_source=syn&utm_medium=rss&utm_campaign=tagWed, 11 Feb 2009 10:50:01 CSThttp://www.newser.com/story/50169/fda-approves-drug-made-from-gene-tweaked-goats.html?utm_source=syn&utm_medium=rss&utm_campaign=tagAn FDA decision to approve a drug made from genetically engineered goats is being called a milestone decision likely to lead to many more "pharm animals," the Boston Globe reports. Biotech firm GTC says the milk from a single genetically modified goat can produce as much of the human anti-bloodclotting...http://www.newser.com/story/50169/fda-approves-drug-made-from-gene-tweaked-goats.html?utm_source=syn&utm_medium=rss&utm_campaign=tagSat, 07 Feb 2009 7:07:35 CSThttp://www.newser.com/story/48751/fda-oks-pioneering-stem-cell-trial.html?utm_source=syn&utm_medium=rss&utm_campaign=tagThe FDA has approved the world's first-ever human trial of a medical treatment using embryonic stem cells, the New York Times reports. The move is being hailed as a watershed moment for medical research. Biotech company Geron plans to inject the cells—which can turn into any type of cell...http://www.newser.com/story/48751/fda-oks-pioneering-stem-cell-trial.html?utm_source=syn&utm_medium=rss&utm_campaign=tagFri, 23 Jan 2009 3:00:36 CSThttp://www.newser.com/story/48347/biotech-boom-finally-fizzles.html?utm_source=syn&utm_medium=rss&utm_campaign=tagIn the bullish market, biotechnology was flush with investment, even though one drug might take many as 15 years and as much as a billion dollars to produce—but those days are over for the riskiest technology sector. Portfolio reports that 45% of publicly traded biotech companies will run out...http://www.newser.com/story/48347/biotech-boom-finally-fizzles.html?utm_source=syn&utm_medium=rss&utm_campaign=tagWed, 21 Jan 2009 7:00:00 CSThttp://www.newser.com/story/47564/engineered-goats-may-usher-in-new-age-of-drugs.html?utm_source=syn&utm_medium=rss&utm_campaign=tagGoats could be the pharma factories of tomorrow: Genetic engineering can prompt them to make a protein in their milk to fight excessive blood clotting. A medication culled from the process was greeted warmly yesterday by an expert panel, and now the FDA is looking into it. If approved, the...http://www.newser.com/story/47564/engineered-goats-may-usher-in-new-age-of-drugs.html?utm_source=syn&utm_medium=rss&utm_campaign=tagSat, 10 Jan 2009 12:30:01 CSThttp://www.newser.com/story/43322/ailing-biotech-firms-need-shot-in-the-arm.html?utm_source=syn&utm_medium=rss&utm_campaign=tagFor the first time in years, the biotech industry is in desperate need of a lifeline, Bloomberg reports, as the economic crisis threatens to shove companies into bankruptcy and derail the development of potentially life-saving drugs. “I’m looking down the barrel of a gun,” admitted one CEO. Five such companies...http://www.newser.com/story/43322/ailing-biotech-firms-need-shot-in-the-arm.html?utm_source=syn&utm_medium=rss&utm_campaign=tagFri, 21 Nov 2008 13:05:01 CST